Treating Atrial Fibrillation is No Maze: A Reminder to Heart Teams for Concomitant Surgical Ablation for Atrial

Raghav Chandra1, Jason Guo2, Jewon Sohn2

  • 1Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.

Insights

Concomitant surgical ablation (CSA) effectively treats atrial fibrillation (AF) during heart surgery, yet its adoption remains low. This review highlights CSA

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is the most common cardiac arrhythmia.
  • AF frequently coexists with conditions requiring cardiac surgery, such as coronary artery disease and valvular heart disease.
  • Surgical ablation, particularly the Cox-Maze IV procedure, is effective for AF management.

Purpose of the Study:

  • To review the indications, efficacy, and safety of concomitant surgical ablation (CSA) for AF.
  • To discuss the challenges in implementing CSA during cardiac surgical procedures.
  • To encourage wider adoption of CSA when clinically indicated.

Main Methods:

  • This is a review article, synthesizing existing literature on surgical ablation for AF.
  • The review examines data on efficacy, safety, and implementation challenges.
  • Focus is on AF treatment during concomitant cardiac surgeries like coronary revascularization and valve repair/replacement.

Main Results:

  • Surgical ablation is highly effective in restoring normal sinus rhythm.
  • CSA demonstrates efficacy in preventing atrial tachyarrhythmias and reducing stroke risk.
  • The safety profile of CSA is favorable when performed with other cardiac surgeries.

Conclusions:

  • Despite strong guideline recommendations, CSA for AF is underutilized.
  • Multidisciplinary heart teams should consider CSA for eligible AF patients undergoing cardiac surgery.
  • Addressing implementation challenges is key to increasing CSA adoption.